Page 77 - Read Online

Boyajian et al. Microbiome Res Rep 2024;3:29 https://dx.doi.org/10.20517/mrr.2024.05 Page 29 of 35

review and meta-analysis. Aging 2022;14:477-96. DOI PubMed PMC
64. Almeida HM, Sardeli AV, Conway J, Duggal NA, Cavaglieri CR. Comparison between frail and non-frail older adults’ gut
microbiota: a systematic review and meta-analysis. Ageing Res Rev 2022;82:101773. DOI PubMed
65. Palmas V, Pisanu S, Madau V, et al. Gut microbiota markers and dietary habits associated with extreme longevity in healthy sardinian
centenarians. Nutrients 2022;14:2436. DOI PubMed PMC
66. Biagi E, Franceschi C, Rampelli S, et al. Gut microbiota and extreme longevity. Curr Biol 2016;26:1480-5. DOI
67. Luan Z, Sun G, Huang Y, et al. Metagenomics study reveals changes in gut microbiota in centenarians: a cohort study of Hainan
centenarians. Front Microbiol 2020;11:1474. DOI PubMed PMC
68. Sepp E, Smidt I, Rööp T, et al. Comparative analysis of gut microbiota in centenarians and young people: impact of eating habits and
childhood living environment. Front Cell Infect Microbiol 2022;12:851404. DOI PubMed PMC
69. Pang S, Chen X, Lu Z, et al. Longevity of centenarians is reflected by the gut microbiome with youth-associated signatures. Nat
Aging 2023;3:436-49. DOI
70. Zhang S, Zeng B, Chen Y, et al. Gut microbiota in healthy and unhealthy long-living people. Gene 2021;779:145510. DOI
71. Wilmanski T, Diener C, Rappaport N, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat
Metab 2021;3:274-86. DOI PubMed PMC
72. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123-40. DOI PubMed
73. Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol
2020;11:594150. DOI PubMed PMC
74. Ghosh S, Lertwattanarak R, Garduño Jde J, et al. Elevated muscle TLR4 expression and metabolic endotoxemia in human aging. J
Gerontol A Biol Sci Med Sci 2015;70:232-46. DOI PubMed PMC
75. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related
diseases. Nat Rev Endocrinol 2018;14:576-90. DOI PubMed
76. Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr
2020;74:1251-62. DOI PubMed
77. Vatanen T, Kostic AD, d’Hennezel E, et al; DIABIMMUNE Study Group. Variation in microbiome LPS immunogenicity contributes
to autoimmunity in humans. Cell 2016;165:842-53. DOI PubMed PMC
78. Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB. Obesity-induces organ and tissue specific tight junction restructuring and barrier
deregulation by claudin switching. Sci Rep 2017;7:5125. DOI PubMed PMC
79. Nagpal R, Newman TM, Wang S, Jain S, Lovato JF, Yadav H. Obesity-linked gut microbiome dysbiosis associated with
derangements in gut permeability and intestinal cellular homeostasis independent of diet. J Diabetes Res 2018;2018:3462092. DOI
PubMed PMC
80. Yao D, Dai W, Dong M, Dai C, Wu S. MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis. EBioMedicine
2021;74:103751. DOI PubMed PMC
81. Hussain M, Umair Ijaz M, Ahmad MI, et al. Meat proteins in a high-fat diet have a substantial impact on intestinal barriers through
mucus layer and tight junction protein suppression in C57BL/6J mice. Food Funct 2019;10:6903-14. DOI
82. Ghosh TS, Shanahan F, O'Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol
2022;19:565-84. DOI PubMed PMC
83. Wu M, Wu Y, Li J, Bao Y, Guo Y, Yang W. The dynamic changes of gut microbiota in Muc2 deficient mice. Int J Mol Sci
2018;19:2809. DOI PubMed PMC
84. Chen Z, Luo J, Li J, et al. Foxo1 controls gut homeostasis and commensalism by regulating mucus secretion. J Exp Med
2021;218:e20210324. DOI PubMed PMC
85. Tran L, Greenwood-Van Meerveld B. Age-associated remodeling of the intestinal epithelial barrier. J Gerontol A Biol Sci Med Sci
2013;68:1045-56. DOI PubMed PMC
86. Oami T, Abtahi S, Shimazui T, et al. Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and
mortality in sepsis. Proc Natl Acad Sci U S A 2024;121:e2217877121. DOI PubMed PMC
87. Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, gut microbiota, and obesity: links with host genetics
and epigenetics and potential applications. Adv Nutr 2019;10:S17-30. DOI PubMed PMC
88. Anachad O, Taouil A, Taha W, Bennis F, Chegdani F. The implication of short-chain fatty acids in obesity and diabetes. Microbiol
Insights 2023;16:11786361231162720. DOI PubMed PMC
89. Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett 2014;588:4223-33.
DOI PubMed PMC
90. Ecklu-Mensah G, Choo-Kang C, Maseng MG, et al. Gut microbiota and fecal short chain fatty acids differ with adiposity and country
of origin: the METS-microbiome study. Nat Commun 2023;14:5160. DOI PubMed PMC
91. de la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, et al. Higher fecal short-chain fatty acid levels are associated with gut
microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients 2018;11:51. DOI PubMed PMC
92. Rampelli S, Candela M, Turroni S, et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging
2013;5:902-12. DOI PubMed PMC
93. Jones ML, Martoni CJ, Ganopolsky JG, Labbé A, Prakash S. The human microbiome and bile acid metabolism: dysbiosis,
dysmetabolism, disease and intervention. Expert Opin Biol Ther 2014;14:467-82. DOI PubMed